Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-24
DOI
10.3389/fonc.2020.00005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release
- (2018) Pengkai Ma et al. ACS Applied Materials & Interfaces
- Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma
- (2018) Ke Duan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting FBPase is an emerging novel approach for cancer therapy
- (2018) Gao-Min Liu et al. Cancer Cell International
- ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia
- (2018) Cheng-cheng Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy
- (2018) Yunli Shi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
- (2018) Yunjie Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer
- (2018) Laura Graham et al. INVESTIGATIONAL NEW DRUGS
- Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
- (2018) Tianxiao Gong et al. Journal of Translational Medicine
- PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer
- (2018) Tingting Yang et al. ONCOGENE
- Mitochondrial dynamics and metastasis
- (2018) Dario C. Altieri CELLULAR AND MOLECULAR LIFE SCIENCES
- Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro
- (2018) Tao Jiang et al. OncoTargets and Therapy
- Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
- (2018) Jayshree Hirpara et al. Redox Biology
- Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
- (2018) Matilda Lee et al. Redox Biology
- Development of GLUT4-selective antagonists for multiple myeloma therapy
- (2017) Changyong Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fructose-1,6-bisphosphatase-1 decrease may promote carcinogenesis and chemoresistance in cervical cancer
- (2017) Haoran Li et al. Molecular Medicine Reports
- Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
- (2017) Xueyan Zhang et al. Molecular Medicine Reports
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
- (2017) Xiaoling Qian et al. Oncotarget
- Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
- (2017) Xing Wang et al. Scientific Reports
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
- (2016) Carly C. Barron et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A
- (2016) JIAXIN FU et al. Molecular Medicine Reports
- PKM2 and cancer: The function of PKM2 beyond glycolysis
- (2016) GAOCHAO DONG et al. Oncology Letters
- Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
- (2016) Heba Alshaker et al. Oncotarget
- Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
- (2016) Gabriela Jiménez-Valerio et al. Cell Reports
- Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
- (2016) Laura Pisarsky et al. Cell Reports
- MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
- (2016) Chenwei Pan et al. PLoS One
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- (2015) Benjamin Le Calvé et al. NEOPLASIA
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- Targeting mitochondrial function for the treatment of breast cancer
- (2014) Cláudia M Deus et al. Future Medicinal Chemistry
- Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil
- (2014) XIANGYONG LI et al. Molecular Medicine Reports
- Beyond Warburg effect – dual metabolic nature of cancer cells
- (2014) Jiansheng Xie et al. Scientific Reports
- INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells
- (2013) Joong Won Min et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A growing role for mTOR in promoting anabolic metabolism
- (2013) Jessica J. Howell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin
- (2013) Yao-Dong Wang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
- (2012) Y. H. Ko et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Metabolic symbiosis in cancer: Refocusing the Warburg lens
- (2012) Erica C. Nakajima et al. MOLECULAR CARCINOGENESIS
- Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
- (2011) Y. Zhao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- mTOR links oncogenic signaling to tumor cell metabolism
- (2011) Jessica L. Yecies et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
- (2010) Caroline Jose et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
- (2009) Shih-Hsin Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity
- (2009) N. Bellance et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
- (2009) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
- (2008) B. C. Fuchs et al. CANCER RESEARCH
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started